Diagnosis and treatment of hepatocellular carcinoma

Acta Gastro-Enterologica Belgica

Volumn 62, Issue 4, 1999, Pages 410-414

  Suarez, Y ^a   Sala, M ^a   Llovet, J M ^a   Bruix, J ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Diagnosis; Hepatocellular carcinoma; Prognosis; Treatment

Indexed keywords

ALCOHOL; GELFOAM; INTERFERON; IODINATED POPPYSEED OIL; OCTREOTIDE; TAMOXIFEN;

ARTIFICIAL EMBOLISM; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER IMMUNOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER STAGING; CLINICAL PROTOCOL; CONFERENCE PAPER; DIAGNOSTIC APPROACH ROUTE; EARLY DIAGNOSIS; HUMAN; LIVER CELL CARCINOMA; LIVER RESECTION; LIVER TRANSPLANTATION; PROGNOSIS; SCLEROTHERAPY; TREATMENT INDICATION;

CARCINOMA, HEPATOCELLULAR; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; PALLIATIVE CARE; PROGNOSIS;

EID: 0033375025     PISSN: 00015644     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (44)

1. BRUIX J., CASTELLS A., BRÚ C. Características clínicas y pronóstico del carcinoma hepatocelular. Existen diferencias geográficas ? Gastroenterol y Hepatol., 1991, 14 : 70-74.
2. TSUKUMA H., HIYAMA T., TANAKA S., NAKAO M., YABUUCHI T., KITAMURA T., NAKANISHI K., FUJIMOTO I., INOUE A., YAMAZAKI H., KAWASHIMA T. Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N. Engl. J. Med., 1993, 328: 1797-1801.
3. COLOMBO M., DE FRANCHIS R., DEL NINNO E., SANGIOVANNI A., DE FAZIO C., TOMMASINI M., DONATO M.F., PIVA A., DI CARLO V., DIOGUARDI N. Hepatocellular carcinoma in Italian patients with cirrhosis. N. Engl. J. Med., 1991, 325 : 675-680.
4. IKEDA K , SAITOH S., KOIDA I., ARASE Y., TSUBOTA A., CHAYAMA K., KUMADA H., KAWANISHI M. A multivariate analysis of risk factors for hepatocellular carcinoma : a prospective observation of 795 patients with viral and alcoholic cirrhosis. Hepatology, 1993, 18 : 47-53.
5. POYNARD T., AUBERT A., LAZIZI Y., BEDOSSA P., HAMELIN B., TERRIS B., NAVEU S., DUBREUIL P., PILLOT J., CHAPUT J.C. Independent risk factors for hepatocellular carcinoma in French drinkers. Hepatology, 1991, 13 : 896-901.
6. BORZIO M., BRUNO S., RONCALLI M., COLLOREDO G., RAMELLA G., BORZIO F., LEANDRO G., SERVIDA., E., PODDA M. Liver cell dysplasia is a major risk factor for hepatocellular carcinoma in cirrhosis: A prospective study. Gastroenterology, 1995, 108 : 812-817.
7. SHIBATA M., MORIZANE T., UCHIDA T., YAMAGAMI T., ONOZUKA Y., NAKANO M., MITAMURA K., UENO Y. Irregular regeneration of hepatocytes and risk of hepatocellular carcinoma in chronic hepatitis and cirrhosis with hepatitis C-virus infection. Lancet. 1998, 351 : 1773-1777.
8. OKUDA K. Early recognition of hepatocellular carcinoma. Hepatology, 1986, 6 : 729-738.
9. LOK A., LAI C.L. Alpha-fetoprotein monitoring Chinese patients with chronic hepatitis B virus infection : role in the early detection of hepatocellular carcinoma. Hepatology, 1989, 9 : 110-115.
10. COLLIER J., SHERMAN M. Screening for hepatocellular carcinoma. Hepatology. 1998, 27 : 273-278.
11. SARASIN F., GIOSTRA E., HADENGUE A. Cost-effectiveness of screening for detection of small hepatocellular carcinoma in western patients with Child-Pugh class A cirrhosis. Am. J. Med., 1996, 171 : 422-434.
12. BIZOLLON T., RODE A., BANCEL B., GUERIPEL V., DUCERF C., BAULIEUX J., TREPO C. Diagnostic value and tolerance of Lipiodol-computed tomography for the detection of small hepatocellular carcinoma : correlation with pathologic examination of explanted livers. J. Hepatol., 1998, 28 : 491-496.
13. CALVET X., BRUIX J., GINÉS P., BRU C, SOLÉ M., VILANA R., RODÉS J. Prognostic factors of hepatocellular carcinoma in the west : A multivariate analysis in 206 patients. Hepatology, 1990, 12 : 753-760.
14. OKUDA K., OHTSUKI T. OBATA H., TOMIMATSU M., OKASAKI N., HASEGAWA H., NAKAJIMA Y, OHNISHI K. Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer, 1985, 56 : 918-928.
15. LLOVET J.M., BUSTAMANTE J., CASTELLS A., VILANA R., AYUSO C., SALA M., BRÚ C., RODÉS J., BRUIX J. Natural history of untreated nonsurgical hepatocellular carcinoma : Rationale for the design and evaluation of therapeutic trials. Hepatology, 1999, 29 : 62-67.
16. BRUIX J. Treatment of hepatocellular carcinoma. Hepatology, 1997, 25 : 259-262.
17. TRINCHET J.C., BEAUGRAND M. Treatment of hepatocellular carcinoma in patients with cirrhosis. J. Hepatol., 1997, 27 : 756-765.
18. LLOVET J.M., BRUIX J., FUSTER J., BRU C., VILANA R., CAPURRO S. and the Liver Cancer Study Group. Long-term outcome after radical treatment for hepatocellular carcinoma : A single center experience. Hepatology, 1998, 28 : 304A.
19. KUBOTA K., MAKUUCHI M., KUSAKA K., KOBAYASHI T., MIKI K., HASEGAWA K., HARIHARA Y., TAKAYAMA T. Measurement of liver volume and hepatic functional reserve as a guide to decision making in resectional surgery for hepatic tumors. Hepatology, 1997, 26 : 1176-1181.
20. BRUIX J., CASTELLS A., BOSCH J., FEU F., FUSTER J., GARCÍA-PAGAN J.C., VISA J., BRÚ C., RODÉS J. Surgical resection of hepatocellular carcinoma in cirrhotic patients : Prognostic value of preoperative portal pressure. Gastroenterology, 1996, 111 : 1018-1022.
21. MAKUUCHI M. Surgical treatment for hepatocellular carcinoma. In : ARROYO V., BOSCH J., RODÉS J. (eds). Treatments in Hepatology. Barcelona : Masson, 1995, 341-352.
22. OKADA S., SHIMADA K., YAMAMOTO J., TAKAYAMA T., KOSUGE T., YAMASAKI S., SOKAMOTO M., HIROHASHI S. Predictive factors for postoperative recurrence of hepatocellular carcinoma. Gastroenterology, 1994, 106 : 1618-1624.
23. MUTO Y., MORIWAKI H., NINOMIYA M., ADACHI S., SAITO A., TANAKA T., TSURUMI K., OKUNO M., TOMITA E., NAKAMURA T., KOJIMA T., for the Hepatoma Prevention Study Group. Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. N. Engl. J. Med., 1996, 334 : 1561-1567.
24. LAU W.Y., LEUNG TWT., H.O S.K.W., CHAN M., MACHIN D., LAU J., CHAN A.T.C., YEO W., MOK T.S.K., YU S.C.H., LEUNG N.W.Y., JOHNSON P.J. Adjuvant intra-arterial iodine 131-labelled lipiodol for resectable hepatocellular carcinoma : a prospective randomised trial. Lancet, 1999, 353 : 797-801.
25. PICHLMAYR R., WEIMANN A., OLDHAFER K.J., SCHLITT H.Y., KLEMPNAUER J., BORNSCHEUER A., CHAVAN A., SCHMOLL E., LANG H., TUSCH G. et al. Role of liver transplantation in the treatment of unresectable liver cancer. World J Surg., 1995, 19: 807-813.
26. STONE M.J., KLINTMALM G.B., POLTER D., HUSBERG B.S., MENNEL R.G., RAMSAY M.A.E., FLEMENS E.E., GOLDSTEIN R.M. Neoadjuvant chemoterapy and liver transplantation for hepatocellular carcinoma : A pilot study in 20 patients. Gastroenterology, 1993, 104: 196-202.
27. BISMUTH H., MORINO M., SHERLOCK D., CASTAING D., MIGLIETTA C., CAUQUIL P., ROCHE A. Primary treatment of hepatocellular carcinoma by arterial chemoembolization. Am. J. Surg., 1992, 163 : 387-394.
28. LLOVET J.M., BRUIX J., FUSTER J., CASTELLS A., GARCIA-VALDECASAS J.C., GRANDE L., FRANÇA A., BRÚ C., NAVASA M., AYUSO M., SOLE M., REAL M.I., VILANA R., RIMOLA A., VISA J., RODÉS J. Liver transplantation for treatment of small hepatocellular carcinoma : The TNM classification does not have prognostic power. Hepatology, 1998, 27 : 1572-1577.
29. MAZZAFERRO V., REGALIA E., DOCI R., ANDREOLA S., PULVIRENTI A., BUZZETTI M., MONTALTO F., AMMANUTA M., MORABITO A., GENNARI L. Liver transplantation for the treatment of small hepatocellular carcinoma in patients with cirrhosis. N. Engl. J. Med., 1996, 334 : 693-699.
30. VILANA R., BRUIX J., BRÚ C., AYUSO C., SOLE M., RODÉS J. Tumor size determines the efficacy of percutaneous ethanol injection for the treatment of small hepatocellular carcinoma. Hepatology, 1992, 16 : 353-357.
31. CASTELLS A., BRUIX J., BRÚ C., FUSTER J., VILANA R., NAVASA M., AYUSO C., BOIX J., RODÉS J. Treatment of small hepatocellular carcinoma in cirrhotic patients : a cohort study comparing surgical resection and percutaneous ethanol injection. Hepatology, 1993, 18: 1121-1126.
32. HONDA N., GUO Q., UCHIDA H., OHISHI H., HIASA Y. Percutaneous hot saline injection therapy for hepatic tumors : An alternative to percutaneous ethanol injection therapy. Radiology, 1994, 190 : 53-57.
33. OHNISHI K., NOMURA F., ITO S., FUJIWARA K. Prognosis of small hepatocellular carcinoma (less than 3 cm) after percutaneous acetic acid injection : study of 91 cases. Hepalology, 1996, 23 : 994-1002.
34. ROSSI S., DI STASI M., BUSCARINO E., CAVANNA L., QUARETTI P., SQUASSANTE E., GARBAGNATI F., BUSCARINI L. Percutaneous radiofrequency interstitial thermal ablation in the treatment of small hepatocellular carcinoma. Cancer J. Sci. Am., 1995, 1 : 73-81.
35. KALAYCI C., JOHNSON P.J., RABY N., METIVIER E.M., WILLIAMS R. Intraarterial adriamycin and lipiodol for inoperable hepatocellular carcinoma : a comparison with intravenous adriamycin. J Hepatology, 1990, 11 : 349-352.
36. Groupe d'Etude et de Traitement du Carcinome Hepatocellulaire. A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. N. Engl. J. Med., 1995, 332 : 1256-1261.
37. PELLETIER G., ROCHE A., INK O., ANCIAUX M.L., DERHY S.,., ROUGIER P., LENOIR C., ATTALI P., ETIENNE J.P. A randomised trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma. J. Hepatol., 1990, 11 : 181-184.
38. BRUIX J., LLOVET J.M., CASTELLS A., MONTAÑÁ X., BRÚ C., AYUSO M.., VILANA R.., RODÉS J. Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma : results of a randomised, controlled trial in a single institution. Hepatology, 1998, 27 : 1578-1583.
39. MARTÍNEZ CEREZO F., TOMAS A., DONOSO L., ENRIQUEZ J., GUARNER C., BALANZÓ J., MARTÍNEZ NAGUERAS A., VILARDELL F. Controlled trial of tamoxifen in patients with advanced hepatocellular carcinoma. J. Hepatol., 1994, 20 : 702-6.
40. FARINATI F., DE MARIA N., FORNASIERO A., SALVAGNINI M., FAGIUOLI S., CHIARAMONTE M., NACCARATO R. Prospective controlled trial with antiestrogen drug tamoxifen in patients with unresectable hepatocellular carcinoma. Dig. Dis. Sci., 1992, 37 : 659-662.
41. CASTELLS A., BRUIX J., BRÚ C., AYUSO C., ROCA M., BOIX L., VILANA R., RODÉS J. Treatment of hepatocellular carcinoma with tamoxifen: a double-blind placebo-controlled trial in 120 patients. Gastroenterology, 1995, 109 : 917-922.
42. CLIP Group. Tamoxifen in treatment of hepatocellular carcinoma : a randomised controlled trial. Lancet, 1998, 352 : 17-20.
43. LAI C.L., LAU J.Y., WU P.C., NGAN H., CHUNG H.T., MITCHELL T.J., CHOW A.W.C., LIN H.J. Recombinant interferon-alpha in inoperable hepatocellular carcinoma : a randomised controlled trial. Hepatology, 1993, 17 : 389-394.
44. KOUROUMALIS E., SKORDILIS P., THERMOS K., VASILAKI A., MOSCHANDREA J., MANOUSOS O.N. Treatment of hepatocellular carcinoma with octreotide : a randomised controlled study. Gut, 1998, 42 : 442-447.